![Edwin Naylor](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Edwin Naylor
Chief Executive Officer at EnMed MicroAnalytics, Inc.
Edwin Naylor active positions
Companies | Position | Start | End |
---|---|---|---|
Parabase Genomics, Inc.
![]() Parabase Genomics, Inc. Medical/Nursing ServicesHealth Services Parabase Genomics, Inc. offers neonatal and pediatric diagnostics. The firm offers neonatal care through the development of early diagnostics for actionable inherited disorders. The company was founded by Gabor Bethlendy and Andy Bhattacharjee is headquartered in Boston, MA. | Director/Board Member | - | - |
EnMed MicroAnalytics, Inc. | Chief Executive Officer | 01/01/2017 | - |
Founder | - | - |
Career history of Edwin Naylor
Former positions of Edwin Naylor
Companies | Position | Start | End |
---|---|---|---|
DiaVacs, Inc.
![]() DiaVacs, Inc. BiotechnologyHealth Technology DiaVacs, Inc. develops and commercializes cell-based therapies for the treatment of type 1 diabetes. The company is based in La Jolla, CA. The company was founded by Dietrich A. Stephan, Nick Giannoukakis, and David L. Finegold. Alan J. Lewis has been the CEO of the company since 2015. | Director/Board Member | - | - |
Statistics
International
United States | 4 |
Operational
Director/Board Member | 2 |
Chief Executive Officer | 1 |
Founder | 1 |
Sectoral
Health Services | 2 |
Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 3 |
---|---|
Parabase Genomics, Inc.
![]() Parabase Genomics, Inc. Medical/Nursing ServicesHealth Services Parabase Genomics, Inc. offers neonatal and pediatric diagnostics. The firm offers neonatal care through the development of early diagnostics for actionable inherited disorders. The company was founded by Gabor Bethlendy and Andy Bhattacharjee is headquartered in Boston, MA. | Health Services |
DiaVacs, Inc.
![]() DiaVacs, Inc. BiotechnologyHealth Technology DiaVacs, Inc. develops and commercializes cell-based therapies for the treatment of type 1 diabetes. The company is based in La Jolla, CA. The company was founded by Dietrich A. Stephan, Nick Giannoukakis, and David L. Finegold. Alan J. Lewis has been the CEO of the company since 2015. | Health Technology |
EnMed MicroAnalytics, Inc. |
- Stock Market
- Insiders
- Edwin Naylor
- Experience